{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:32:05Z","timestamp":1789565525443,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K2322"],"award-info":[{"award-number":["20K2322"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ajem.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T06:33:59Z","timestamp":1665729239000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis"],"prefix":"10.1016","volume":"62","author":[{"given":"Daisuke","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Im","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narut","family":"Prasitlumkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshay","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2022.10.006_bb0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1586\/erc.10.161","article-title":"Angiotensin II, tissue factor and the thrombotic paradox of hypertension","volume":"8","author":"Celi","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ajem.2022.10.006_bb0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.07.008","article-title":"Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study","volume":"177","author":"Koh","year":"2004","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.ajem.2022.10.006_bb0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13054-021-03725-z","article-title":"Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study","volume":"25","author":"Flannery","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2022.10.006_bb0025","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","article-title":"Renin as a marker of tissue-perfusion and prognosis in critically ill patients","volume":"47","author":"Gleeson","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"issue":"264\u20139","key":"10.1016\/j.ajem.2022.10.006_bb0040","first-page":"W64","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajem.2022.10.006_bb0050","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM consensus conference committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest."},{"key":"10.1016\/j.ajem.2022.10.006_bb0055","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international Sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama."},{"key":"10.1016\/j.ajem.2022.10.006_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajem.2022.10.006_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajem.2022.10.006_bb0075","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.119.13197","article-title":"Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after Sepsis: a population-based cohort study","volume":"75","author":"Hsu","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.ajem.2022.10.006_bb0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/SHK.0000000000001382","article-title":"Preadmission antihypertensive drug use and Sepsis outcome: impact of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)","volume":"53","author":"Hsieh","year":"2020","journal-title":"Shock (Augusta, Ga)."},{"key":"10.1016\/j.ajem.2022.10.006_bb0090","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15178","article-title":"Chronic use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers is high among intensive care unit patients with non-COVID-19 Sepsis but carries a moderately increased risk of death","volume":"75","author":"Sunden-Cullberg","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.ajem.2022.10.006_bb0100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3349\/ymj.2013.54.4.965","article-title":"Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes","volume":"54","author":"Suh","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ajem.2022.10.006_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.medin.2016.07.010","article-title":"Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury","volume":"41","author":"Suberviola","year":"2017","journal-title":"Med Intensiva"},{"key":"10.1016\/j.ajem.2022.10.006_bb0110","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2215\/CJN.05480610","article-title":"Predictors of acute kidney injury in septic shock patients: an observational cohort study","volume":"6","author":"Plataki","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajem.2022.10.006_bb0115","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1592\/phco.27.12.1619","article-title":"Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis","volume":"27","author":"Mortensen","year":"2007","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.ajem.2022.10.006_bb0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3904\/kjim.2019.262","article-title":"Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis","volume":"36","author":"Lee","year":"2021","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000003654","article-title":"Effect of antihypertensive medications on Sepsis-related outcomes: a population-based cohort study","volume":"47","author":"Kim","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.153986","article-title":"RAS inhibition and sepsis-associated acute kidney injury","volume":"69","author":"Flannery","year":"2022","journal-title":"J Crit Care"},{"key":"10.1016\/j.ajem.2022.10.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002729","article-title":"Evaluation of vasopressin for septic shock in patients on chronic renin-angiotensin-aldosterone system inhibitors","volume":"45","author":"Erwin","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004872","article-title":"Prior exposure to angiotensin II receptor blockers in patients with septic shock to individualize mean arterial pressure target? A post hoc analysis of the sepsis and mean arterial pressure (SEPSISPAM) trial","volume":"49","author":"Demiselle","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SHK.0000000000001524","article-title":"Hemodynamic impact of cardiovascular antihypertensive medications in patients with Sepsis-related acute circulatory failure","volume":"54","author":"de Roquetaillade","year":"2020","journal-title":"Shock (Augusta, Ga)"},{"key":"10.1016\/j.ajem.2022.10.006_bb0150","doi-asserted-by":"crossref","first-page":"9367873","DOI":"10.1155\/2022\/9367873","article-title":"Construction and validation of a risk prediction model for acute kidney injury in patients suffering from septic shock","volume":"2022","author":"Yue","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.ajem.2022.10.006_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of angiotensin II type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertension."},{"key":"10.1016\/j.ajem.2022.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","article-title":"Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis","volume":"29","author":"Bucher","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0001-5172.2004.00283.x","article-title":"The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model","volume":"48","author":"Laesser","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ajem.2022.10.006_bb0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajem.2022.10.006_bb0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-015-0802-3","article-title":"Angiotensin II in septic shock","volume":"19","author":"Corr\u00eaa","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2022.10.006_bb0180","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201307-1321OC","article-title":"Risk of cardiovascular events in survivors of severe sepsis","volume":"189","author":"Yende","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajem.2022.10.006_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022870","article-title":"Effects of renin-angiotensin-aldosterone system inhibitors on long-term major adverse cardiovascular events in Sepsis survivors","volume":"10","author":"Ou","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajem.2022.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bcp.12419","article-title":"Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis","volume":"78","author":"Dial","year":"2014","journal-title":"Br J Clin Pharmacol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722006362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722006362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:30Z","timestamp":1760025810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722006362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"alternative-id":["S0735675722006362"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.10.006","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}